Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 6-Month Open-Label Extension Study of the Long-Term Safety of DVS SR in Outpatients With Fibromyalgia Syndrome.

NCT00424892 is registered in ClinicalTrials.gov with Wyeth is now a wholly owned subsidiary of Pfizer as lead sponsor.

NCT NCT00424892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00424892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 6-Month Open-Label Extension Study of the Long-Term Safety of DVS SR in Outpatients With Fibromyalgia Syndrome.
Lead sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Phase
Phase 2/3
Overall status
Completed
Start date
Not reported
Completion date
June 30, 2007
Enrollment
600
Sites
59

Conditions

As the registry lists them; a condition with its own page is linked.

fibromyalgia